Article By:
Benzinga
Sunday, August 29, 2021 4:30 PM EDT
Biopharma stocks had a strong start to the week amid optimism generated by full approval accorded to the mRNA vaccine developed by Pfizer, Inc. and BioNTech SE. The stocks subsequently moved back and forth in a narrow range before ending higher.